Skip to main content
VulnerabilityPublished

CVE-2026-39444: PublishPress PublishPress Series organize-series · Authorization Bypass Through User-Controlled Key Vulnerability

Source GCVE Database

0
Compare
Authoritative record:CVE-2026-39444· Medium 5.4

Not known to be exploited · CVSS 5.4 Medium : upgrade to 3.1.4 when convenient.

Data as of 16 Nov 2026, 20:25 UTC

CVSS 3.1 base score
5.4Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 8% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 3.1.4
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:L

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 2 Oct 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 16 Nov 2026.

What to do

Upgrade PublishPress Series to 3.1.4.

Affected software

ProductAffectedFixed in
PublishPressPublishPress SeriesAffected
  • <3.1.4
Fixed in
  • 3.1.4

AI-suggested

If you cannot patch yet, review and tighten access control configurations to reduce risk from user-controlled keys if possible.

Description

CVE-2026-39444 is an authorization bypass vulnerability in PublishPress Series up to version 3.1.3. It involves exploitation of incorrectly configured access control security levels via a user-controlled key. This flaw allows an attacker with limited privileges to bypass authorization checks, potentially leading to limited integrity and availability impacts. The vulnerability has a medium severity rating with a CVSS score of 5.4.

References

Community reviews

Loading reviews…